B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SIRT1

MOLECULAR TARGET

sirtuin 1

UniProt: Q96EB6NCBI Gene: 2341115 compounds

SIRT1 (sirtuin 1) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SIRT1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1isoliquiritigenin4.5089
2sirtinol3.4330
3gf 1092033.4029
4bisindolylmaleimide ix3.1422
5gw305074x3.1422
6cambinol2.9418
7suramin hexasodium2.8316
8fenamic acid2.7114
9gartanin2.7114
10salermide2.5612
11paullone2.4811
12Suramin2.309
13Resveratrol2.087
14oblongifolin c2.087
15anilinobenzamide1.795

About SIRT1 as a Drug Target

SIRT1 (sirtuin 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented SIRT1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SIRT1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.